🟢 Biovie is trading 9.5% up in pre-market alongside XBI's 3.64% pre-market gain

Biovie is trading at $1.38, up 9.52%, alongside broader biotech-sector strength; that context does not establish the cause of the gain.

• XBI is up 3.64% pre-market, supporting a sector explanation without confirming it.
• No new company-specific announcement for October 22 was identified in the available news results. Recent coverage focused on BioVie’s October 20 Parkinson’s presentation and October 19 Long COVID presentation.